Hulme JP - Search Results

1

Current status of fluid biomarkers for early Alzheimer's disease and FDA regulation implications.

Jamerlan AM, An SSA, Hulme JP. Jamerlan AM, et al. Among authors: hulme jp. J Neurol Sci. 2024 Dec 15;467:123325. doi: 10.1016/j.jns.2024.123325. Epub 2024 Nov 22. J Neurol Sci. 2024. PMID: 39615439 Review.

2

Mitochondrial therapeutic interventions in Alzheimer's disease.

Van Giau V, An SSA, Hulme JP. Van Giau V, et al. Among authors: hulme jp. J Neurol Sci. 2018 Dec 15;395:62-70. doi: 10.1016/j.jns.2018.09.033. Epub 2018 Sep 28. J Neurol Sci. 2018. PMID: 30292965 Review.

3

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.

Giau VV, Wu SY, Jamerlan A, An SSA, Kim SY, Hulme J. Giau VV, et al. Nutrients. 2018 Nov 14;10(11):1765. doi: 10.3390/nu10111765. Nutrients. 2018. PMID: 30441866 Free PMC article. Review.

4

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer's disease.

An SSA, Hulme JP. An SSA, et al. Among authors: hulme jp. Neural Regen Res. 2023 Nov;18(11):2391-2392. doi: 10.4103/1673-5374.371361. Neural Regen Res. 2023. PMID: 37282463 Free PMC article. No abstract available.

5

Mammalian Models in Alzheimer's Research: An Update.

Sharma H, Chang KA, Hulme J, An SSA. Sharma H, et al. Cells. 2023 Oct 16;12(20):2459. doi: 10.3390/cells12202459. Cells. 2023. PMID: 37887303 Free PMC article. Review.

6

Current applications of graphene oxide in nanomedicine.

Wu SY, An SS, Hulme J. Wu SY, et al. Int J Nanomedicine. 2015 Aug 26;10 Spec Iss(Spec Iss):9-24. doi: 10.2147/IJN.S88285. eCollection 2015. Int J Nanomedicine. 2015. PMID: 26345988 Free PMC article. Review.

7

Diminazene aceturate: an antibacterial agent for Shiga-toxin-producing Escherichia coli O157:H7.

Wu SY, Park GY, Kim SH, Hulme J, An SS. Wu SY, et al. Drug Des Devel Ther. 2016 Oct 14;10:3363-3378. doi: 10.2147/DDDT.S114832. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27789937 Free PMC article.

8

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.

Van Giau V, An SSA, Hulme J. Van Giau V, et al. Drug Des Devel Ther. 2019 Jan 18;13:327-343. doi: 10.2147/DDDT.S190577. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 30705582 Free PMC article. Review.

9

Recent advances in the treatment of C. difficile using biotherapeutic agents.

Giau VV, Lee H, An SSA, Hulme J. Giau VV, et al. Infect Drug Resist. 2019 Jun 10;12:1597-1615. doi: 10.2147/IDR.S207572. eCollection 2019. Infect Drug Resist. 2019. PMID: 31354309 Free PMC article.

10

SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus.

Van Vo G, Bagyinszky E, Park YS, Hulme J, An SSA. Van Vo G, et al. Adv Exp Med Biol. 2021;1321:3-19. doi: 10.1007/978-3-030-59261-5_1. Adv Exp Med Biol. 2021. PMID: 33656709 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters